A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain.
Sci Immunol
; 5(47)2020 05 01.
Article
in En
| MEDLINE
| ID: mdl-32358170
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Viral Fusion Proteins
/
Respiratory Syncytial Virus, Human
/
Respiratory Syncytial Virus Vaccines
/
Nanoparticles
/
Antibodies, Neutralizing
/
Antibodies, Viral
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Sci Immunol
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: